I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 22% ± 5% | |
| epithelial cell | 6 studies | 32% ± 13% | |
| type I pneumocyte | 6 studies | 22% ± 4% | |
| fibroblast | 5 studies | 21% ± 3% | |
| squamous epithelial cell | 4 studies | 40% ± 19% | |
| abnormal cell | 4 studies | 21% ± 3% | |
| GABAergic neuron | 4 studies | 34% ± 8% | |
| goblet cell | 4 studies | 22% ± 3% | |
| oligodendrocyte | 4 studies | 19% ± 2% | |
| classical monocyte | 3 studies | 18% ± 2% | |
| neuron | 3 studies | 29% ± 5% | |
| pericyte | 3 studies | 16% ± 1% | |
| smooth muscle cell | 3 studies | 17% ± 1% | |
| basal cell | 3 studies | 22% ± 8% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 5% | |
| glutamatergic neuron | 3 studies | 47% ± 3% | |
| oligodendrocyte precursor cell | 3 studies | 25% ± 6% |
